Category Archives: Science

Science Press Releases & News distributed via EuropaWire

Neuberger Berman, EQT, and CPP Investments Lead USD 14.5 Billion Acquisition of Nord Anglia Education

(IN BRIEF) Neuberger Berman, EQT, and CPP Investments, along with a consortium of global investors, have signed agreements to acquire Nord Anglia Education for USD 14.5 billion. Nord Anglia, a leading international schools organization with over 80 schools in 33 … Read the full press release

Wainzua Receives EU Recommendation for Treating Hereditary Amyloidosis, Offering New Monthly Self-Administered Option

(IN BRIEF) AstraZeneca and Ionis’ drug Wainzua (eplontersen) has been recommended for approval in the European Union for treating hereditary transthyretin-mediated amyloidosis (ATTRv-PN) in adults with stage 1 or 2 polyneuropathy. Based on the positive results from the NEURO-TTRansform Phase … Read the full press release

GSK and Cambridge University Join Forces with £50 Million Investment to Tackle Kidney and Respiratory Diseases Using AI

(IN BRIEF) GSK and the University of Cambridge have announced a £50 million, five-year collaboration called the Cambridge-GSK Translational Immunology Collaboration (CG-TIC) to accelerate research and development in kidney and respiratory diseases. The initiative combines GSK’s expertise in immunology and … Read the full press release

Novo Nordisk’s Oral Semaglutide Reduces Cardiovascular Risk by 14% in Type 2 Diabetes Patients, SOUL Trial Shows

(IN BRIEF) Novo Nordisk’s SOUL trial has shown that oral semaglutide reduces the risk of major adverse cardiovascular events (MACE) by 14% in adults with type 2 diabetes and established cardiovascular disease or chronic kidney disease. The trial involved 9,650 … Read the full press release

Sanofi and CD&R Join Forces to Propel Opella’s Global Consumer Healthcare Expansion

(IN BRIEF) Sanofi and CD&R have entered exclusive negotiations for CD&R to acquire a 50% controlling stake in Opella, Sanofi’s consumer healthcare business, while Sanofi retains a significant share. The partnership aims to support Opella’s growth as a global leader … Read the full press release

University of York Researchers Investigate the Threat of Climate Change and Flooding on Earthworm Populations

(IN BRIEF) Researchers at the University of York, led by Professor Mark Hodson, are launching a two-year study to examine how climate change and increasing flooding in the UK are affecting earthworm populations. Earthworms play a vital role in maintaining … Read the full press release

Novo Nordisk’s Alhemo® Recommended for European Approval as First Once-Daily Subcutaneous Treatment for Haemophilia A and B with Inhibitors

(IN BRIEF) Novo Nordisk’s Alhemo® (concizumab) has been recommended for approval by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP). If approved, Alhemo® will become the first once-daily subcutaneous prophylactic treatment for people aged 12 … Read the full press release

Sanofi and Orano Med Partner to Drive Development of Advanced Radioligand Cancer Therapies

(IN BRIEF) Sanofi and Orano Med have partnered to accelerate the development of next-generation radioligand therapies (RLTs) for rare cancers. By combining their expertise, they aim to advance treatments using lead-212 (212Pb) alpha-emitting isotopes, which target and destroy cancer cells … Read the full press release

German Researchers Advance 6G Technology with Focus on Security, Digital Twins, and Telediagnostics

(IN BRIEF) Researchers at the Technical University of Munich (TUM) and TU Dresden are leading initiatives to develop 6G mobile communication technologies, with commercial availability expected by 2030. These projects focus on key advancements such as digital twins for reliable … Read the full press release

Aalborg University Researchers Discover Genetic Marker Linked to Severe Ulcerative Colitis, Paving the Way for Personalized Treatment

(IN BRIEF) Researchers have identified the genetic variant HLA-DRB1*01:03, which is strongly linked to severe ulcerative colitis. About 3% of patients carry this variant, and of those, over 40% required major surgery within three years of diagnosis. (PRESS RELEASE) AALBORG, … Read the full press release

AstraZeneca Presents New Data at IDWeek 2024, Showcasing Progress in Respiratory Disease Prevention and Vaccine Innovation

(IN BRIEF) AstraZeneca presented significant advancements in the prevention of infectious diseases at IDWeek 2024, showcasing its dedication to addressing respiratory infections caused by RSV, hMPV, and COVID-19. The company revealed promising data across its portfolio, including Beyfortus, an antibody … Read the full press release

University of York Alumnus Daron Acemoglu Wins Nobel Prize for Research on Economic Prosperity and Institutions

(IN BRIEF) University of York alumnus Daron Acemoglu has been awarded the Nobel Prize in Economic Sciences, alongside Simon Johnson and James A. Robinson, for their research on how societal institutions influence a country’s economic prosperity. Their work highlights the … Read the full press release

Fresenius Medical Care Unveils Xenios 2.0: Next-Generation ECLS System with Advanced Safety and Connectivity Features

(IN BRIEF) Fresenius Medical Care’s subsidiary, Xenios AG, has launched Xenios 2.0, a new system for extracorporeal life support (ECLS) that serves patients from neonates to adults. Approved under the new Medical Device Regulation (MDR), Xenios 2.0 offers advanced safety … Read the full press release

BASF and Acadian Plant Health Partner to Launch Seaweed Biostimulants for Climate-Resilient Farming

(IN BRIEF) BASF has partnered with Acadian Plant Health™ to expand its BioSolutions portfolio by incorporating seaweed-based biostimulants. These biostimulants, derived from Ascophyllum nodosum, help crops withstand stressors like heat and drought, supporting sustainable agriculture. The collaboration will distribute these … Read the full press release

EIB Global Invests €2 Million in Vaccine Development at Akagera Medicines in Rwanda

(IN BRIEF) The European Investment Bank (EIB Global) has committed €2 million to support Akagera Medicines Africa Limited in Rwanda, facilitating the early-stage development of vaccines for infectious diseases, including tuberculosis, HIV, Ebola, and Lassa fever. This funding aims to … Read the full press release

Eviden Unveils Innovative “Cloud for Clinics” Platform to Transform Healthcare in DACH Region

(IN BRIEF) Eviden, a division of the Atos Group, has unveiled its “Cloud for Clinics,” a secure and pre-integrated platform tailored for healthcare providers in Germany and the DACH region, built on Amazon Web Services (AWS). This initiative aims to … Read the full press release

University of Liverpool and Roche Diagnostics Unite to Drive Health Innovation and Address Inequalities

(IN BRIEF) The University of Liverpool has signed a Memorandum of Understanding (MoU) with Roche Diagnostics UK and Ireland to enhance research and innovation focused on improving health outcomes and addressing health inequalities. This partnership aims to align with Roche’s … Read the full press release

GSK Reports Promising Phase III Findings for Depemokimab in Treating Chronic Rhinosinusitis with Nasal Polyps

(IN BRIEF) GSK plc has announced positive results from its Phase III ANCHOR trials for depemokimab, a biologic treatment for chronic rhinosinusitis with nasal polyps (CRSwNP). The trials demonstrated a significant reduction in nasal polyp size and nasal obstruction after … Read the full press release

Roche’s Evrysdi Shows Remarkable Motor and Cognitive Outcomes in Children with SMA After Two Years of Early Treatment

(IN BRIEF) Roche has announced positive two-year data from its RAINBOWFISH study, showcasing the effectiveness of Evrysdi® (risdiplam) in treating children with spinal muscular atrophy (SMA) when administered before symptoms appear. The study revealed that most children achieved key motor … Read the full press release

Enhertu by AstraZeneca and Daiichi Sankyo Approved in China as First HER2-Directed Therapy for Metastatic Lung Cancer

(IN BRIEF) AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has received conditional approval in China for the treatment of patients with unresectable, locally advanced, or metastatic non-small cell lung cancer (NSCLC) with HER2 (ERBB2) mutations who have previously undergone systemic … Read the full press release

New Research Links Mitochondrial Dysfunction to Crohn’s Disease, Offering Hope for Targeted Treatments

(IN BRIEF) Researchers at the Technical University of Munich have found that mitochondrial dysfunction in the intestines can trigger Crohn’s disease symptoms by disrupting the gut microbiome. This groundbreaking discovery establishes a direct link between defective mitochondria and both tissue … Read the full press release

SETsquared and QantX Launch £300 Million Investment Fund to Boost Science and Technology Spin-Outs in the South and South West

(IN BRIEF) The SETsquared Partnership universities, including the University of Southampton, and QantX have launched a £300 million investment vehicle to accelerate the growth of science and technology companies. This initiative aims to address funding disparities in the region and … Read the full press release

EIB and LUMICKS Partner to Accelerate Cancer Drug Discovery with €20 Million Investment in Advanced Immunotherapy Tools

(IN BRIEF) Amsterdam-based LUMICKS has secured €20 million in venture debt from the European Investment Bank (EIB) to advance its next-generation cell avidity platform, which aims to accelerate the development of immunotherapies for cancer treatment. Supported by the InvestEU initiative, … Read the full press release

Merck Opens €290 Million Biosafety Testing Facility in Rockville to Enhance Drug Safety and Accelerate Testing Timelines

(IN BRIEF) Merck has officially opened a new €290 million biosafety testing facility in Rockville, Maryland, designed to meet the increasing global demand for biosafety testing services. This state-of-the-art facility consolidates various operations, including biosafety testing, analytical development, and cell … Read the full press release

Unilever Sells Russian Subsidiary to Arnest Group, Concluding Operations in the Country

(IN BRIEF) On October 10, 2024, Unilever announced the successful sale of its Russian subsidiary to Arnest Group, a local manufacturer specializing in perfumes, cosmetics, and household products. This transaction encompasses Unilever’s entire operations in Russia, including its four production … Read the full press release

Roche Secures CE Certification for Groundbreaking Companion Diagnostic Aiding Gastric Cancer Treatment

(IN BRIEF) Roche has announced the CE certification of its VENTANA CLDN18 (43-14A) RxDx Assay, marking a significant advancement in companion diagnostics for patients with gastric and gastroesophageal junction (GEJ) adenocarcinoma. This diagnostic tool enables clinicians to identify patients who … Read the full press release

NIB Supports FinVector’s New Gene Therapy Facility in Kuopio to Enhance Cancer Treatment Capabilities

(IN BRIEF) FinVector, a leading biopharmaceutical company, has inaugurated a cutting-edge production facility in Kuopio, Finland, aimed at manufacturing gene therapy products. The new Finport facility, which is set to become one of the world’s largest for such therapies, represents … Read the full press release

The Road to Sustainable Electric Motors for EVs: IDTechEx Analyzes Key Factors

(IN BRIEF) Electric vehicles (EVs) are essential for decarbonizing the transport sector, yet concerns regarding the sustainability of materials used in their electric motors persist. A recent IDTechEx report predicts a demand for over 160 million electric motors annually by … Read the full press release

Loughborough University’s Vicky Goosey-Tolfrey Honored as Outstanding Woman in STEM at East Midlands Women’s Awards

(IN BRIEF) Professor Vicky Goosey-Tolfrey of Loughborough University has been awarded the Outstanding Woman in STEM at the East Midlands Women’s Awards (EMWA) for her significant contributions to the fields of science, technology, engineering, and mathematics, particularly within applied disability … Read the full press release

Covestro Paves the Way for Circular Economy with €100 Million Investment in R&D

(IN BRIEF) Covestro has announced a €100 million investment aimed at enhancing its research and development (R&D) infrastructure over the next three years, targeting sustainable solutions and digital advancements. This initiative supports the company’s commitment to becoming fully circular and … Read the full press release

Novo Nordisk Launches Global Childhood Obesity Initiative to Support Healthier Urban Communities

(IN BRIEF) Novo Nordisk has launched the Childhood Obesity Prevention Initiative, aimed at combating rising obesity rates among children in underserved urban communities across six cities worldwide. Backed by an investment of over 250 million Danish kroner and a coalition … Read the full press release

Hera Mission Launched to Explore Asteroid Deflection Techniques and Safeguard Earth from Potential Threats

(IN BRIEF) The Hera planetary defense mission, launched successfully aboard a SpaceX Falcon 9 rocket, aims to assess the feasibility of deflecting hazardous asteroids threatening Earth. This mission follows NASA’s DART mission, which tested asteroid deflection by impacting the Dimorphos … Read the full press release

nova-Institute Launches Expert Group to Enhance Biopolymer Insights and Drive Sustainability in the Renewable Carbon Sector

(IN BRIEF) The nova-Institute has announced the formation of a specialized group of biopolymer experts aimed at enhancing market and trend reporting in the renewable carbon sector. This initiative focuses on advancing sustainability in the chemical and materials industries by … Read the full press release

QIAGEN and Neo4j Strengthen Partnership to Revolutionize Biomedical Data Analysis in Biopharma Industry

(IN BRIEF) QIAGEN Digital Insights has announced an expanded partnership with Neo4j, aiming to enhance biomedical data analysis for the biopharmaceutical industry. This collaboration will integrate Neo4j’s graph database and machine learning capabilities with QIAGEN’s extensive biomedical knowledge base. By … Read the full press release

Genetic Resistance to DDT Found in Malaria-Transmitting Mosquitoes Due to Historical Insecticide Use

(IN BRIEF) Scientists have identified the first instances of genetic mutations in Anopheles funestus mosquitoes that confer resistance to DDT, a previously widespread insecticide now banned due to environmental concerns. This discovery, made by researchers from the University of Glasgow … Read the full press release

Beiersdorf Sets Bold Net Zero Targets by 2045, Reinforcing Commitment to Sustainability at Hamburg Conference

(IN BRIEF) Beiersdorf, a leading skincare company, has announced its ambitious sustainability goals during the Hamburg Sustainability Conference. The company aims to achieve Net Zero emissions by 2045 and intends to reduce emissions across its entire value chain by 90%. … Read the full press release

Fabentech Secures €20 Million EIB Loan to Bolster Pandemic Preparedness and Biological Threat Response

(IN BRIEF) Fabentech, a French biopharmaceutical company, has secured a €20 million loan from the European Investment Bank (EIB) through the HERA Invest initiative. The funding will support Fabentech’s research, bioproduction, and expansion of its FabShield® technology, which focuses on … Read the full press release

Early Success: AstraZeneca’s Airsupra Proves Highly Effective in Reducing Severe Asthma Risks in Phase III Trial

(IN BRIEF) AstraZeneca’s inhaled rescue medication, Airsupra (albuterol/budesonide), has shown significant efficacy in reducing the risk of severe asthma exacerbations in patients with intermittent or mild persistent asthma, according to high-level results from the BATURA Phase IIIb trial. The trial … Read the full press release

Breakthrough Peptide Inhibitor Targets Tau Protein Aggregation, Paving the Way for New Alzheimer’s Treatments

(IN BRIEF) An international team of researchers has made a significant breakthrough in Alzheimer’s drug development with the introduction of RI-AG03, a novel peptide inhibitor that targets and inhibits two key aggregation-promoting hotspots of the Tau protein, which is critical … Read the full press release

University of Twente to Launch First Bilingual Bachelor’s Degree in Psychology in 2025

(IN BRIEF) The University of Twente has announced the introduction of a bilingual Bachelor’s Degree in Psychology for the 2025-2026 academic year, becoming the first program of its kind at the university. This initiative, approved by the University Council, will … Read the full press release